title: Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial.
abstract: OBJECTIVE
  To evaluate the safety and effectiveness of accelerated partial breast irradiation (APBI) with multi-catheter brachytherapy.
  
  
  METHODS
  Between 11/2000 and 04/2005, 274 patients participated. Patients were eligible for APBI if they had histologically confirmed breast cancer, a tumour diameter 3cm, complete resection with clear margins 2mm, negative axillary lymph nodes or singular nodal micro-metastasis, no distant metastases, hormone receptor-positive tumours, and were >/= 35 years. Patients were excluded if mammographically they showed a multicentric invasive growth pattern, poorly differentiated tumours, residual diffuse micro-calcifications, extensive intraductal component, or vessel invasion. Median follow-up was 32 months (range; 8-68).
  
  
  RESULTS
  The local control rate was 99.3% (272/274), the 3 year-local-recurrence-free survival probability, 99.6%. Peri-operative complications occurred in 5.5% (15/274): 9 (3.3%) experienced implant infection and 6 (2.2%) hematoma. Acute toxicity (Grade 1/2 radio-dermatitis) was seen in 6.6% (18/274). Late side effects >/= Grade 3 (fibrosis, telangiectasia) occurred in 1.8% (4/274). Cosmetic results were excellent/good in 94% (253/274).
  
  
  CONCLUSIONS
  This analysis underlined the safety and effectiveness of APBI in a carefully selected subgroup with favourable disease characteristics. Of course, longer follow-up and randomised trials are necessary to conclusively assess the potential of APBI.
authors.affiliation: University Hospital Erlangen, Department of Radiation Oncology, Erlangen, Germany. oliver.ott@strahlen.imed.uni-erlangen.de
authors.forename: Oliver J
authors.initials: OJ
authors.lastname: Ott
authors.forename: Guido
authors.initials: G
authors.lastname: Hildebrandt
authors.forename: Richard
authors.initials: R
authors.lastname: Pötter
authors.forename: Josef
authors.initials: J
authors.lastname: Hammer
authors.forename: Michael
authors.initials: M
authors.lastname: Lotter
authors.forename: Alexandra
authors.initials: A
authors.lastname: Resch
authors.forename: Rolf
authors.initials: R
authors.lastname: Sauer
authors.forename: Vratislav
authors.initials: V
authors.lastname: Strnad
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods*; D001943:Breast Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053208:Kaplan-Meier Estimate; D015412:Mastectomy, Segmental; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome